Article

Payers Restrict Coverage for Proton Radiation Therapy

Weighing the cost-benefit ratio of proton radiation therapy, private and public payers are placing coverage limitations on the use of this treatment.

As proton cancer treatment centers expand, payers and providers may have to collaborate to expand the evidence base, to avoid the highly-expensive technology crowding out other investments.

The Midwest’s first proton beam cancer therapy center is closing its doors amid ongoing efficacy questions and financial struggles. At the advice of an outside review committee, Indiana University Health is closing its proton therapy center early next year, once the current roster of patients have completed treatment.

IU Health’s center was the nation’s third proton treatment facility and the Midwest’s first when it opened in 2004. It offered cancer patients the potential of more selective radiation treatment with fewer side effects, but ten years later, its clinical benefits remain unclear, its technology is slightly outdated and its finances seem unsustainable.

Read the complete article: http://bit.ly/1sYeOOB

Source: Healthcare Payer News

Related Videos
Wanmei Ou, PhD, vice president of product, data analytics, and AI at Ontada
Glenn Balasky, executive director of the Rocky Mountain Cancer Center.
Corey McEwen, PharmD, MS
dr linda bosserman
dr andrew leitner
Glenn Balasky during a video interview
dr joseph alvarnas
dr joseph alvarnas
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo